12.30-1.30pm, Mon 20th August 2018
Seminar Room 515, Level 5, 207 Bouverie Street, Carlton
Professor Nancy Devlin, Director of Research, Office of Health Economics, London, U.K.
Assessing the cost effectiveness of new medicines relies on the measurement of quality of life (QoL). For two decades, the National Institute of Health and Care Excellence (NICE) in England has recommended use of the EQ-5D, a concise, generic measure of QoL. Continue reading “MSPGH Special Seminar: 20th August 2018 – Measuring quality of life for Health Technology Appraisal: the challenge of switching ‘instruments’”